Marco Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $830K | Hold |
4,916
| – | – | 0.06% | 125 |
|
|
2025
Q4 | $830K | Buy |
4,916
+30
| +0.6% | +$4.87K | 0.06% | 124 |
|
|
2025
Q3 | $705K | Hold |
4,886
| – | – | 0.05% | 131 |
|
|
2025
Q2 | $618K | Hold |
4,886
| – | – | 0.05% | 135 |
|
|
2025
Q1 | $625K | Hold |
4,886
| – | – | 0.06% | 132 |
|
|
2024
Q4 | $646K | Buy |
4,886
+700
| +17% | +$98.4K | 0.06% | 134 |
|
|
2024
Q3 | $609K | Hold |
4,186
| – | – | 0.05% | 136 |
|
|
2024
Q2 | $575K | Hold |
4,186
| – | – | 0.05% | 137 |
|
|
2024
Q1 | $574K | Hold |
4,186
| – | – | 0.05% | 137 |
|
|
2023
Q4 | $569K | Sell |
4,186
-2,000
| -32% | -$244K | 0.06% | 133 |
|
|
2023
Q3 | $756K | Sell |
6,186
-100
| -2% | -$12.7K | 0.09% | 121 |
|
|
2023
Q2 | $798K | Buy |
6,286
+422
| +7% | +$54.8K | 0.09% | 123 |
|
|
2023
Q1 | $757K | Hold |
5,864
| – | – | 0.09% | 128 |
|
|
2022
Q4 | $770K | Hold |
5,864
| – | – | 0.09% | 127 |
|
|
2022
Q3 | $686K | Buy |
5,864
+80
| +1% | +$9.93K | 0.09% | 129 |
|
|
2022
Q2 | $680K | Sell |
5,784
-29,450
| -84% | -$3.5M | 0.08% | 133 |
|
|
2022
Q1 | $4.59M | Hold |
35,234
| – | – | 0.47% | 62 |
|
|
2021
Q4 | $5.38M | Buy |
35,234
+2,100
| +6% | +$325K | 0.53% | 56 |
|
|
2021
Q3 | $5.36M | Hold |
33,134
| – | – | 0.59% | 48 |
|
|
2021
Q2 | $5.42M | Hold |
33,134
| – | – | 0.63% | 44 |
|
|
2021
Q1 | $4.99M | Hold |
33,134
| – | – | 0.65% | 44 |
|
|
2020
Q4 | $5.02M | Hold |
33,134
| – | – | 0.72% | 39 |
|
|
2020
Q3 | $4.49M | Buy |
33,134
+30,039
| +971% | +$4.08M | 0.74% | 43 |
|
|
2020
Q2 | $423K | Hold |
3,095
| – | – | 0.08% | 121 |
|
|
2020
Q1 | $333K | Hold |
3,095
| – | – | 0.07% | 130 |
|
|
2019
Q4 | $373K | Hold |
3,095
| – | – | 0.06% | 141 |
|
|
2019
Q3 | $308K | Hold |
3,095
| – | – | 0.05% | 147 |
|
|
2019
Q2 | $338K | Hold |
3,095
| – | – | 0.06% | 141 |
|
|
2019
Q1 | $346K | Buy |
3,095
+50
| +2% | +$5.48K | 0.06% | 142 |
|
|
2018
Q4 | $294K | Hold |
3,045
| – | – | 0.06% | 150 |
|
|
2018
Q3 | $371K | Hold |
3,045
| – | – | 0.05% | 152 |
|
|
2018
Q2 | $334K | Hold |
3,045
| – | – | 0.05% | 158 |
|
|
2018
Q1 | $325K | Sell |
3,045
-300
| -9% | -$33.3K | 0.05% | 158 |
|
|
2017
Q4 | $357K | Buy |
3,345
+3
| +0.1% | +$321 | 0.05% | 153 |
|
|
2017
Q3 | $371K | Buy |
+3,342
| New | +$357K | 0.06% | 157 |
|
|
2017
Q2 | – | Sell |
-3,339
| Closed | -$327K | – | 179 |
|
|
2017
Q1 | $327K | Hold |
3,339
| – | – | 0.06% | 155 |
|
|
2016
Q4 | $295K | Buy |
+3,339
| New | +$304K | 0.05% | 157 |
|
Other funds holding IBB
CB
Marco Investment Management's IBB Position: Q1 2026 in Review
Marco Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 4,916 shares worth $830K. The position accounts for 0.06% of the portfolio, ranked #125.
Marco Investment Management first reported a position in IBB in Q4 2016 and has held it in 37 quarters since. The position peaked at $5.42M in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Marco Investment Management held 4,916 shares of iShares Biotechnology ETF worth $830K as of Q1 2026.
- Marco Investment Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.06% of Marco Investment Management's portfolio in Q1 2026, its #125 holding.
- Marco Investment Management first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 37 quarters since.
- Marco Investment Management's iShares Biotechnology ETF position peaked at $5.42M in Q2 2021.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.